Hormonal treatments can improve moderate acne, but safety rules and evidence gaps limit who benefits. This 2026 guide maps those limits to practical questions for your dermatology visit. Hormonal therapy here means drugs that reduce androgen-driven oil, or sebum, production.
Some hormonal options carry acne approval, while other uses rest on weaker evidence. Clot, blood pressure, potassium, and pregnancy risks shape screening and follow-up. Use the sections below to check eligibility and plan monitoring.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Which combined pills are approved for acne?
- How strong is the evidence?
- Who should avoid combined pills?
- What safety checks apply to spironolactone and isotretinoin?
Which combined pills are approved for acne?
Optum Perks, summarizing FDA listings, identifies four approved combination pills for moderate acne the Optum Perks summary of FDA listings. They are Ortho Tri-Cyclen, Estrostep Fe, Yaz and Beyaz. Approval applies when you also want contraception. They lower androgens and sebum.
That link to contraception matters for choice. If pregnancy prevention is not a goal, discuss non-contraceptive acne options first. If it is a goal, you can weigh acne benefit with birth-control needs together. Response varies by person and product. Track breakouts, bleeding changes, mood, and blood pressure for review.
How strong is the evidence?
The American Academy of Dermatology gave only conditional recommendations for combined oral contraceptives and spironolactone in its 2024 acne guidelines the Academy's updated acne guidelines. Conditional means moderate-certainty evidence with need for individualized decisions. Benefit is likely for some patients, not assured for all. The same 2024 Academy guidelines found evidence insufficient to recommend chemical peels, laser and light devices, microneedling, dietary changes, vitamins, or plant products for acne.
That finding does not prove these approaches never help. It means trials were too limited to support routine use. This contrast helps set priorities. Start with options that have clearer support, then treat other methods as experimental add-ons. Ask what outcome would justify continuing or stopping each choice.
Who should avoid combined pills?
The Food and Drug Administration warns the FDA Yasmin label that drospirenone pills may carry higher clot risk. Examples include Yaz and Yasmin, and risk differs from pills with other progestins. All combined pills raise clot risk compared with nonuse.
NIH DailyMed labeling for Tri-Sprintec lists contraindications tied to cardiovascular risk. Do not use combined pills with smoking over age 35, prior clots, stroke, heart attack, uncontrolled hypertension, or migraine with aura. Bring a clear history to screening. Note smoking, blood pressure readings, migraine with visual changes, and clot events in you or close relatives.
- Smoking status and age, blood pressure history, migraine pattern
- Personal or family history of clots, stroke, or heart attack
- Other estrogen-containing drugs and planned surgery or long travel
What safety checks apply to spironolactone and isotretinoin?
NIH DailyMed spironolactone labeling notes acne use is entirely off-label; approval covers heart failure, hypertension, and edema. The drug is a potassium-sparing diuretic that can raise potassium. Monitoring is needed, with avoidance in renal impairment and pregnancy. Oral isotretinoin for severe recalcitrant acne requires iPLEDGE safety enrollment, reports the National Community Pharmacists Association the Association's FDA update.
Prescriber and pharmacy certification plus pregnancy testing apply because the drug causes birth defects. Modifications in 2026 allow at-home tests during treatment while keeping in-clinic pre-treatment testing. Ask these questions at prescribing to clarify follow-up and pregnancy safeguards. Bring a full drug list and blood pressure history to that visit.
- Do I need baseline and follow-up potassium or kidney checks for spironolactone?
- Could pregnancy, breastfeeding, or planned pregnancy rule out these options?
- What iPLEDGE steps, test timing, and pharmacy rules apply to me?